Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.22.2.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 27 Months Ended
Sep. 02, 2021
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2022
Apr. 14, 2022
Subsidiary, Sale of Stock [Line Items]          
Price per share (in dollars per share)   $ 3.04 $ 3.04 $ 3.04  
Unused capacity   $ 26.4 $ 26.4 $ 26.4  
Committed Equity Facility          
Subsidiary, Sale of Stock [Line Items]          
Derivative asset   $ 0.8 $ 0.8 $ 0.8  
Shares from transaction (in shares) 8,500,000 310,815 310,815 127,751  
Sale of stock, amount authorized to issue and sell         $ 80.0
Percentage of purchase price per share         97.00%
Percentage of commission on gross proceeds   3.00% 3.00% 3.00%  
Remaining shares available   8,689,185 8,689,185 8,689,185  
Committed Equity Facility | Minimum          
Subsidiary, Sale of Stock [Line Items]          
Price per share (in dollars per share)   $ 3.87 $ 3.87 $ 3.87  
Committed Equity Facility | Maximum          
Subsidiary, Sale of Stock [Line Items]          
Price per share (in dollars per share)   $ 4.29 $ 4.29 $ 4.29